Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.
暂无分享,去创建一个
T. Sugiyama | E. Isogai | Kenichi Sato | S. Hayashi | H. Isogai | Mayumi Tanaka | K. Hirose | K. Kimura
[1] A. Gasbarrini,et al. Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.
[2] M. Martínez,et al. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones. , 2000, The Journal of antimicrobial chemotherapy.
[3] C. Nord,et al. Microbial Ecology and Treatment of Helicobacter pylori Infections: Review , 2000, Journal of chemotherapy.
[4] E. Hahn,et al. Helicobacter pylori associated gastric pathology. , 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[5] G. Adler,et al. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. , 1999, Scandinavian journal of gastroenterology.
[6] J. Sung,et al. An Increase in Helicobacter pylori Strains Resistant to Metronidazole: A Five‐Year Study , 1996, Helicobacter.